MoneyWorks4Me

Gland Pharma - Quaterly Results

21 Jan 2022 Evaluate
The company witnessed a 23.73% growth in the revenue at Rs. 10633.25 millions for the quarter ended December 2021 as compared to Rs. 8594.19 millions during the year-ago period.A comparatively good net profit growth of 33.94% to Rs. 2733.84 millions was reported for the quarter ended December 2021 compared to Rs. 2041.07 millions of previous same quarter.Operating profit surged to 3949.35 millions from the corresponding previous quarter of 2993.62 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 10633.25 8594.19 23.73 32976.94 25751.28 28.06 34628.76 26332.40 31.51
Other Income 456.69 351.30 30.00 1587.06 875.62 81.25 1347.76 1391.68 -3.16
PBIDT 3949.35 2993.62 31.93 13209.14 10621.15 24.37 14370.43 10946.35 31.28
Interest 11.83 11.59 2.07 32.08 23.90 34.23 34.11 71.82 -52.51
PBDT 3937.52 2982.03 32.04 13177.06 10597.25 24.34 14336.32 10874.53 31.83
Depreciation 278.34 249.65 11.49 792.21 738.58 7.26 987.80 945.87 4.43
PBT 3659.18 2732.38 33.92 12384.85 9858.67 25.62 13348.52 9928.66 34.44
TAX 925.34 691.31 33.85 3123.06 2493.13 25.27 3378.47 2200.08 53.56
Deferred Tax 5.02 -1.25 -501.60 46.85 -11.93 -492.71 1.20 -318.21 -100.38
PAT 2733.84 2041.07 33.94 9261.79 7365.54 25.74 9970.05 7728.58 29.00
Equity 164.30 163.28 0.62 164.30 163.28 0.62 163.59 154.95 5.58
PBIDTM(%) 37.14 34.83 6.63 40.06 41.25 -2.88 41.50 41.57 -0.17
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..